Endogenous H2S sensitizes PAR4-induced bladder pain

Am J Physiol Renal Physiol. 2018 Jun 1;314(6):F1077-F1086. doi: 10.1152/ajprenal.00526.2017. Epub 2018 Jan 10.

Abstract

Bladder pain is a prominent symptom of interstitial cystitis/painful bladder syndrome. Hydrogen sulfide (H2S) generated by cystathionine β-synthase (CBS) or cystathionine γ-lyase (CSE) facilitates bladder hypersensitivity. We assessed involvement of the H2S pathway in protease-activated receptor 4 (PAR4)-induced bladder pain. A bladder pain model was induced by intravesical instillation of PAR4-activating peptide in mice. The role of H2S in this model was evaluated by intraperitoneal preadministration of d,l-propargylglycine (PAG), aminooxyacetic acid (AOAA), or S-adenosylmethionine or the preintravesical administration of NaHS. SV-HUC-1 cells were treated in similar manners. Assessments of CBS, CSE, and macrophage migration inhibitory factor (MIF) expression, bladder voiding function, bladder inflammation, H2S production, and referred bladder pain were performed. The CSE and CBS pathways existed in both mouse bladders and SV-HUC-1 cells. H2S signaling was upregulated in PAR4-induced bladder pain models, and H2S-generating enzyme activity was upregulated in human bladders, mouse bladders, and SV-HUC-1 cells. Pretreatment with AOAA or NaHS inhibited or promoted PAR4-induced mechanical hyperalgesia, respectively; however, PAG only partially inhibited PAR4-induced bladder pain. Treatment with PAG or AOAA decreased H2S production in both mouse bladders and SV-HUC-1 cells. Pretreatment with AOAA increased MIF protein levels in bladder tissues and cells, whereas pretreatment with NaHS lowered MIF protein levels. Bladder pain triggered by the H2S pathway was not accompanied by inflammation or altered micturition behavior. Thus endogenous H2S generated by CBS or CSE caused referred hyperalgesia mediated through MIF in mice with PAR4-induced bladder pain, without causing bladder injury or altering micturition behavior.

Keywords: cystathionine β-synthase; cystathionine γ-lyase; hydrogen sulfide; interstitial cystitis/painful bladder syndrome; migration inhibitory factor; protease-activated receptor 4.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkynes / pharmacology
  • Aminooxyacetic Acid / pharmacology
  • Analgesics / pharmacology
  • Animals
  • Cell Line
  • Cystathionine gamma-Lyase / antagonists & inhibitors
  • Cystathionine gamma-Lyase / metabolism
  • Cystitis, Interstitial / metabolism*
  • Cystitis, Interstitial / pathology
  • Cystitis, Interstitial / physiopathology
  • Cystitis, Interstitial / prevention & control
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • Female
  • Glycine / analogs & derivatives
  • Glycine / pharmacology
  • Humans
  • Hydrogen Sulfide / metabolism*
  • Hyperalgesia / metabolism*
  • Hyperalgesia / pathology
  • Hyperalgesia / physiopathology
  • Hyperalgesia / prevention & control
  • Intramolecular Oxidoreductases / metabolism
  • Ligands
  • Lyases / antagonists & inhibitors
  • Lyases / metabolism
  • Macrophage Migration-Inhibitory Factors / metabolism
  • Mice, Inbred C57BL
  • Pain Threshold* / drug effects
  • Receptors, Thrombin / metabolism*
  • Signal Transduction
  • Sulfides / pharmacology
  • Urinary Bladder / drug effects
  • Urinary Bladder / metabolism*
  • Urinary Bladder / pathology
  • Urinary Bladder / physiopathology

Substances

  • Alkynes
  • Analgesics
  • Enzyme Inhibitors
  • Ligands
  • Macrophage Migration-Inhibitory Factors
  • Receptors, Thrombin
  • Sulfides
  • Aminooxyacetic Acid
  • propargylglycine
  • Lyases
  • Cystathionine gamma-Lyase
  • cystathionine beta-lyase
  • Intramolecular Oxidoreductases
  • MIF protein, human
  • Mif protein, mouse
  • sodium bisulfide
  • protease-activated receptor 4
  • Glycine
  • Hydrogen Sulfide